Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression
about
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression
description
scientific article published on 28 May 2020
@en
name
Alemtuzumab in multiple sclero ...... pite intense immunosuppression
@en
type
label
Alemtuzumab in multiple sclero ...... pite intense immunosuppression
@en
prefLabel
Alemtuzumab in multiple sclero ...... pite intense immunosuppression
@en
P2093
P50
P356
P1476
Alemtuzumab in multiple sclero ...... pite intense immunosuppression
@en
P2093
Andrea Arighi
Daniela Galimberti
Elio Scarpini
Giorgio Giulio Fumagalli
Luca Sacchi
Mattia Pozzato
Milena Alessandra De Riz
P304
1352458520926459
P356
10.1177/1352458520926459
P577
2020-05-28T00:00:00Z